Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Obesity, Anemia, Iron Deficiencies, Bariatric Surgery

In brief

This study aimed to explore the effects of preoperative intravenous isomaltose iron supplementation versus placebo on postoperative Hb improvement, prevention of postoperative anemia, and improvement in quality of life in patients undergoing bariatric surgery.

Key facts

Study ID
NCT07236788
Run by
China-Japan Friendship Hospital
People needed
200
Starts
2025-03-01
Expected to finish
2027-03-30
Last updated by the study team
2025-11-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.